Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila Breidinger

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy and Pharmacology|February 1, 2012
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimusMark Stroh, John Palcza, Jacqueline McCrea, et al.
Journal of Clinical Pharmacology|May 16, 2014
Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: model prediction and clinical confirmationMark Stroh, Jennifer Talaty, Punam Sandhu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2008
Atazanavir modestly increases plasma levels of raltegravir in healthy subjectsMarian Iwamoto, Larissa A Wenning, Goutam C Mistry, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy and Pharmacology|February 1, 2012
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimusMark Stroh, John Palcza, Jacqueline McCrea, et al.
Journal of Clinical Pharmacology|May 16, 2014
Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: model prediction and clinical confirmationMark Stroh, Jennifer Talaty, Punam Sandhu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2008
Atazanavir modestly increases plasma levels of raltegravir in healthy subjectsMarian Iwamoto, Larissa A Wenning, Goutam C Mistry, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Pageof 2